A Medical Device Daily

BioSeek (Burlingame, California), which focuses on applying integrated human biology systems for developing new therapeutics, said that it has entered into a non-exclusive agreement with Boston Scientific (Natick, Massachusetts) to profile compounds for potential applications in new products.

BioSeek has previously demonstrated that its proprietary BioMAP Systems can identify key biological activities of compounds that correlate with clinical efficacy. Under the current agreement with Boston Scientific, which expands earlier collaborations between the companies, BioSeek will screen and evaluate a series of compounds (selected by Boston Scientific) for novel therapeutic uses. Financial terms were not disclosed.

Stereotaxis (St. Louis) said that it has signed a three-year extension to a joint development agreement with Siemens Medical Solutions (Malvern, Pennsylvania). The continuation of the alliance is expected to lead to product line expansion of both companies' integrated systems to meet the growing needs of the market, increased integration in technology to improve clinical work flows for physicians and hospital staff, and will strengthen the coordination of the sales, marketing and service organizations globally. Additionally, the two companies will collaborate to explore potential clinical applications beyond the cardiology market.